Diagnosis-Related Group

Diagnosis-Related Group
Name	Diagnosis-Related Group
Abbreviation	DRG
Introduced	1980s
Country	United States
Developed by	Prospective Payment System
Related	Prospective Payment System, International Classification of Diseases

Diagnosis-Related Group Diagnosis-Related Group is a patient classification scheme for hospital cases designed to inform prospective payment systems and standardized billing for inpatient care. It links clinical conditions and procedures to predetermined payment rates, influencing hospital management, coding practices, and health financing across multiple jurisdictions. The system shaped policymaking debates involving prominent institutions, legislators, and scholarly figures during late 20th-century reforms.

Background and origins

Origins trace to work at Yale University and Harvard University health services researchers and administrators collaborating with policymakers such as officials from the Social Security Administration and the United States Department of Health and Human Services. Early pilots drew on diagnostic taxonomies like the International Classification of Diseases and procedure classifications used by the American Hospital Association and the American Medical Association. The inception involved interactions among leaders at Medicare design groups, analysts at the RAND Corporation, and consultants from McKinsey & Company. Influential reports from commissions including the Gramm-Rudman-Hollings era fiscal debates and hearings before the United States Congress informed adoption amid concerns raised by figures such as policymakers within the Office of Management and Budget and health economists affiliated with Harvard School of Public Health.

Classification and structure

Classification schemes map principal diagnoses, comorbidities, and procedures to discrete categories derived from clinical and resource-use criteria developed by groups like 3M Company and panels convened by the International Society for Pharmacoeconomics and Outcomes Research. The structure often incorporates upcoding countermeasures, relative weight assignments influenced by case-mix indices, and grouping rules that reflect inputs from standards bodies such as the World Health Organization and national coding authorities like the Centers for Medicare & Medicaid Services. Methodological contributions came from researchers at institutions including Johns Hopkins University, Stanford University, and Columbia University, while implementation tools referenced taxonomies used by the National Institutes of Health and classification updates paralleling revisions to ICD-9 and ICD-10.

Payment and reimbursement systems

As a prospective payment foundation, the model underpins tariff-setting approaches adopted in contexts overseen by agencies such as the Centers for Medicare & Medicaid Services, national health insurers like NHS England equivalents, and provincial payers in federations such as Canada's provincial ministries. Payment calculations rely on average length-of-stay metrics, cost-to-charge ratios, and budget-neutrality rules debated in forums including the Brookings Institution and the Kaiser Family Foundation. Adjustments for teaching hospitals used by academic centers like Massachusetts General Hospital and safety-net providers considered indirect medical education payments contested in hearings involving representatives from American College of Surgeons and American Nurses Association.

Implementation by country and variants

Jurisdictions adapted the model to national contexts: variants include adaptations used by Germany (G-DRG), Australia (AR-DRG), France (GHS), and regional systems in Japan (DPC) shaped by ministries such as the Federal Ministry of Health (Germany) and agencies like Agence technique de l'information sur l'hospitalisation. Implementation involved partnerships with vendors including 3M Company and consulting firms like PricewaterhouseCoopers and Deloitte. Case studies from institutions such as Charité in Berlin, Royal Melbourne Hospital in Melbourne, and university hospitals affiliated with University of Tokyo illustrate operational adaptations, while evaluations by international organizations like the Organisation for Economic Co-operation and Development and the World Bank informed cross-country comparisons.

Impact on healthcare quality and utilization

Evidence from empirical studies at centers including Mayo Clinic, Cleveland Clinic, and health systems analyzed by scholars at University of Oxford and London School of Economics reported mixed effects on length of stay, readmission rates, and case-mix complexity. Quality oversight mechanisms invoked accreditation bodies such as The Joint Commission and national quality agencies like Agence nationale de sécurité du médicament et des produits de santé to mitigate unintended incentives. Health services research from think tanks including RAND Corporation and universities like University of California, Berkeley explored relationships between reimbursement incentives and clinical pathways taught at medical schools such as Johns Hopkins School of Medicine and University of Pennsylvania Perelman School of Medicine.

Criticisms and limitations

Critiques raised by stakeholders including physician organizations like the American Medical Association, nursing groups such as the American Nurses Association, and patient advocacy organizations emphasized risks of premature discharge, coding manipulation, and gaming documented in litigation involving hospitals and payers. Academic critics from Yale School of Medicine and policy analysts at Harvard Kennedy School highlighted challenges in capturing complexity for rare diseases and specialty procedures performed at centers like Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. Reform proposals discussed by commissions and policymakers at institutions such as the Institute of Medicine and World Health Organization recommended blended payment models, quality-linked adjustments, and ongoing surveillance by regulatory agencies.

Category:Health care financing